Nonuremic Indication for Peritoneal Dialysis for Refractory Heart Failure in Cardiorenal Syndrome Type II: Review and Perspective
- 1 January 2013
- journal article
- review article
- Published by SAGE Publications in Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis
- Vol. 33 (1) , 8-14
Abstract
Cardiorenal syndrome (CRS) type II is a serious condition in which chronic cardiac abnormalities cause worsening kidney function, leading to permanent chronic kidney damage. Management of CRS type II coupled with diuretic-resistant congestive heart failure (CHF) has been an issue of dispute. However, since the early 1990s, reports indicating the clinical usefulness of peritoneal dialysis (PD) as maintenance therapy for intractable CHF in this population have been accumulating. The present manuscript reviews the mechanisms by which kidney dysfunction develops within CHF, and then examines recent experiences of PD as chronic supportive therapy for intractable CRS type II, reviews the contributing mechanisms, and discusses the rationale for using PD as a new therapeutic approach in the nonuremic setting of CHF.Keywords
This publication has 68 references indexed in Scilit:
- Heart Disease and Stroke Statistics—2011 UpdateCirculation, 2011
- Cardiorenal Syndrome in Acute Heart Failure SyndromesInternational Journal of Nephrology, 2011
- Effect of Right Ventricular Function and Venous Congestion on Cardiorenal Interactions During the Treatment of Decompensated Heart FailureThe American Journal of Cardiology, 2010
- Importance of Venous Congestion for Worsening of Renal Function in Advanced Decompensated Heart FailureJACC, 2009
- Do thiazides worsen metabolic syndrome and renal disease? The pivotal roles for hyperuricemia and hypokalemiaCurrent Opinion in Nephrology and Hypertension, 2008
- Chronic Kidney Disease Associated Mortality in Diastolic Versus Systolic Heart Failure: A Propensity Matched Study††The Digitalis Investigation Group study was conducted and supported by the National Heart, Lung, and Blood Institute in collaboration with the Digitalis Investigation Group Investigators. This manuscript was prepared using a limited access data set obtained by the National Heart, Lung, and Blood Institute and does not necessarily reflect the opinions or views of the Digitalis Investigation Group or the National Heart, Lung, and Blood Institute.The American Journal of Cardiology, 2007
- The role of peritoneal dialysis in the treatment of refractory heart failureNephrology Dialysis Transplantation, 2005
- Long-term successful management of refractory congestive cardiac failure by intermittent ambulatory peritoneal ultrafiltrationQJM: An International Journal of Medicine, 1996
- Clinical and hemodynamic results of peritoneal dialysis for severe cardiac failureAmerican Heart Journal, 1968
- Peritoneal dialysis in the treatment of intractable congestive heart failure of infancy and childhoodThe Journal of Pediatrics, 1966